Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_2
1
10%
Ph not_applicable
4
40%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(3)
Terminated(2)
Other(5)

Detailed Status

unknown4
Completed3
Suspended1
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (20.0%)
N/A4 (80.0%)

Trials by Status

suspended110%
unknown440%
completed330%
terminated110%
withdrawn110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
OTHER
Total Trials
10